ADELE 2 -project develops prototype materials and ways to prevent the development of immune-mediated diseases. The project aims at getting nature exposure from consumer products which include added biodiversity component. These products support the normal development of immune system and protect against immune-mediated diseases. Currently, products containing such components are not available,and therefore the developed technologies can be protected by patents. This will enable the expansion of enterprises in the ADELE 2 -ecosystem to the global market with high added value products.
Background
ADELE 2 -project develops prototype materials and ways to prevent the development of immune-mediated diseases. Such diseases include, for example, most allergies, asthma, autoimmune diseases like rheumatoid arthritis and type 1 diabetes, as well as inflammatory bower diseases. An important common denominator of these diseases is a limited and one-sided microbial exposure, whereas repeated exposure to natures microbial diversity has been considered as a key in protecting against these diseases. In this context, nature exposure means exposure to a diverse microbial community in forests and meadows.
Today, nature exposure must be received by going out into nature, which is difficult if not impossible in urban areas. The ADELE ecosystem project aims at getting this exposure from consumer products which include added biodiversity component. These products support the normal development of immune system and protect against immune-mediated diseases. Currently, products containing such components are not available, and therefore the developed technologies can be protected by patents. This will enable the expansion to the global market with high added value products.
Funding source
Business Finland
Contact persons
Juho Rajaniemi
Principal Investigator / WP7
juho.rajaniemi [at] tut.fi
+358 44 524 7245